> Diabetes Research > Insulin Deficiency in Type 2 Diabetes Solved

Insulin Deficiency in Type 2 Diabetes Solved

Scientists at the Australian Garvan Institute of Medical Research have finally reached a conclusion to the failure of insulin production in type 2 diabetes. Considered a breakthrough in diabetes research, they were successful in isolating the PKCepsilon (PKCe), an enzyme which present during diabetes aria slows down the production of insulin in type 2 diabetics.

Lead authors of the study, Associate Prof. Trevor Biden and Dr. Carsten Schmitz-Peiffer, note that the findings in this study could lead to the development of a medication that restrains the PKCe and allow insulin production in the pancreas. Biden notes that there are a lot of current medications that prompts the body to create insulin, but none has actually developed a drug that addresses the need to stop the PKCe from hindering the pancreas to produce insulin.

Dr.Schmitz-Peiffer is positive about the outcome of further studies on PKCe, saying that it could lead to the safeguarding of individuals who are at high risk in developing type 2 diabetes. “Blocking PKCe won’t stop them from becoming insulin-resistant, but it will restore their capacity to compensate,” he says.

Related terms:

Related Posts:

» Tags: , , ,

Related terms:

Leave a Reply

Your email address will not be published. Required fields are marked *